RxDoctor Payments Data

Maria Litzendorf, MD

Vascular Surgery · Manchester, CTNPI 1598935058

Payments from drug & device makers

What this record shows

This record is dominated by other: $43,779 of the $51,427 with a category attached, or 85.1%. Angiodynamics, Inc. accounts for 86.5% of it on its own, with 30 other manufacturers making up the rest.

$51,427in general payments, 2019–2025

Across 183 payments — averaging $281.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$44K
  • Endologix LLC$3K
  • Medtronic$560
  • W. L. Gore & Associates, Inc.$502
  • Avinger Inc.$467
  • Johnson & Johnson$363
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$7,60015%
  • Education$480%
  • Other$43,77985%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,427 in reported general payments places this provider in the 85th percentile of 82 vascular surgery providers in Connecticut.

See all vascular surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$384,474
Medicare patients
179
Services billed
2,490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate95$500

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Manchester

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →